Thomas Mcnerney & Partners Lp - Net Worth and Insider Trading
Thomas Mcnerney & Partners Lp Net Worth
The estimated net worth of Thomas Mcnerney & Partners Lp is at least $6 Million dollars as of 2024-11-05. Thomas Mcnerney & Partners Lp is the of Zogenix Inc and owns about 215,698 shares of Zogenix Inc (ZGNX) stock worth over $6 Million. Thomas Mcnerney & Partners Lp is also the 10% Owner of Clarus Therapeutics Holdings Inc and owns about 1,745,659 shares of Clarus Therapeutics Holdings Inc (CRXTQ) stock worth over $2,444. Details can be seen in Thomas Mcnerney & Partners Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Mcnerney & Partners Lp has not made any transactions after 2022-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Mcnerney & Partners Lp
Thomas Mcnerney & Partners Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Mcnerney & Partners Lp owns 4 companies in total, including Ocera Therapeutics Inc (OCRX) , Zogenix Inc (ZGNX) , and Clarus Therapeutics Holdings Inc (CRXTQ) among others .
Click here to see the complete history of Thomas Mcnerney & Partners Lp’s form 4 insider trades.
Insider Ownership Summary of Thomas Mcnerney & Partners Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCRX | Ocera Therapeutics Inc | 2017-01-30 | 10 percent owner |
| ZGNX | Zogenix Inc | 2010-11-29 | other: See Footnote (10) |
| CRXTQ | Clarus Therapeutics Holdings Inc | 2022-04-20 | 10 percent owner |
 | | 2021-09-10 | 10 percent owner |
Thomas Mcnerney & Partners Lp Latest Holdings Summary
Thomas Mcnerney & Partners Lp currently owns a total of 2 stocks. Among these stocks, Thomas Mcnerney & Partners Lp owns 215,698 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $6 Million and a weighting of 99.96%. Thomas Mcnerney & Partners Lp also owns 1,745,659 shares of Clarus Therapeutics Holdings Inc (CRXTQ) as of April 20, 2022, with a value of $2,444 and a weighting of 0.04%.
Latest Holdings of Thomas Mcnerney & Partners Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2010-11-29 | 215,698 | 26.68 | 5,754,823 |
| CRXTQ | Clarus Therapeutics Holdings Inc | 2022-04-20 | 1,745,659 | 0.00 | 2,444 |
Holding Weightings of Thomas Mcnerney & Partners Lp
Thomas Mcnerney & Partners Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Mcnerney & Partners Lp has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 22,153 shares on November 29, 2010, which cost Thomas Mcnerney & Partners Lp around $708,896.
According to the SEC Form 4 filings, Thomas Mcnerney & Partners Lp has made a total of 2 transactions in Clarus Therapeutics Holdings Inc (CRXTQ) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Clarus Therapeutics Holdings Inc is the sale of 3,752,912 shares on April 20, 2022, which brought Thomas Mcnerney & Partners Lp around $9 Million.
Insider Trading History of Thomas Mcnerney & Partners Lp
- 1
Thomas Mcnerney & Partners Lp Trading Performance
GuruFocus tracks the stock performance after each of Thomas Mcnerney & Partners Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Mcnerney & Partners Lp is 8.72%. GuruFocus also compares Thomas Mcnerney & Partners Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Mcnerney & Partners Lp within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Mcnerney & Partners Lp's insider trading performs compared to the benchmark.
Performance of Thomas Mcnerney & Partners Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 42.56 | | | | | |
| Relative Return to S&P 500(%) | 36.5 | | | | | |
Thomas Mcnerney & Partners Lp Ownership Network
Ownership Network List of Thomas Mcnerney & Partners Lp
Ownership Network Relation of Thomas Mcnerney & Partners Lp
Thomas Mcnerney & Partners Lp Owned Company Details
What does Ocera Therapeutics Inc do?
Who are the key executives at Ocera Therapeutics Inc?
Thomas Mcnerney & Partners Lp is the 10 percent owner of Ocera Therapeutics Inc. Other key executives at Ocera Therapeutics Inc include 10 percent owner Brian H Dovey , 10 percent owner Domain Partners Viii, L.p. , and 10 percent owner Dp Viii Associates, L.p. .
Ocera Therapeutics Inc (OCRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocera Therapeutics Inc Insider Transactions
Thomas Mcnerney & Partners Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Mcnerney & Partners Lp. You might contact Thomas Mcnerney & Partners Lp via mailing address: 45 S. 7th St., Suite 3060, Minneapolis Mn 55402.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
